Evidence map›Paper›PMID 41189483›Full record

ArticleBJS open2025

Risk factors for hepatocellular carcinoma rupture: multicentre retrospective study.

Feng Xia, Yiyang Liu, Hongwei Huang, Xulin Liu, Jing Yan, Zhancheng Qiu, Qiao Zhang, Zhenheng Wu, Zhiyuan Huang, Renjie Wei and 23 more

Abstract readMulticenter Study
In one paragraph

Article in BJS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Feng XiaDepartment of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Yiyang LiuDepartment of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Hongwei HuangDepartment of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Xulin LiuDepartment of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Jing YanDepartment of Ultrasound in Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China.
Zhancheng QiuDepartment of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
Qiao ZhangDepartment of Hepatic Surgery, Zhongshan People's Hospital Affiliated to Guangdong Medical University, Zhongshan, China.
Zhenheng WuDepartment of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Zhiyuan HuangDepartment of General Surgery, General Hospital of Central Theater Command, Wuhan, China.
Renjie WeiDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Li LinClinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liping LiuDepartment of Hepatobiliary Surgery, Shenzhen People's Hospital, Shenzhen, China.
Shuangqin HanDepartment of Hepatobiliary Surgery, Tianjin First Central Hospital, Tianjin Medical University, Tianjin, China.
Yulin YuanSchool of Medicine, Wuhan University of Science and Technology, Wuhan, China.
Huaxuan YinDepartment of Hepatic-Biliary-Pancreatic Surgery, First People's Hospital of Foshan, Foshan, China.
Guobing XiaDepartment of Hepatobiliary and Pancreatic Surgery, Huangshi Central Hospital, Hubei Polytechnic University, Huangshi, China.
Yunyan WanDepartment of Hepatobiliary Pancreatic Surgery, Taihe Hospital, Shiyan, China.
Shuo XiaoDepartment of Cardiac Surgery, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou, China.
Guoxiang ZhouDepartment of Heart Center, Women and Children's Hospital of Qingdao University, Qingdao, China.
Xiafei XiaDepartment of Organ Transplantation, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, China.
Huapeng SunDepartment of General Surgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Shuai WangDepartment of Hepatobiliary Surgery, Jingzhou Central Hospital, Jingzhou, China.
Jun ZhengDepartment of Science and Education, Shenzhen Baoan District People's Hospital, Guangdong, China.
Hengyi GaoDepartment of Hepatobiliary and Pancreatic Surgery, Shenzhen Longhua District People's Hospital, Guangdong, China.
Jiang ZhengDepartment of Cardiology, Wuhan Yaxin General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Li RenDepartment of Hepatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China.
Ali MoDepartment of General Surgery, First Affiliated Hospital of Shaoyang University, Shaoyang, China.
Lin YeDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China.
Shun RuanDepartment of Surgery, Dongguan Hepatobiliary Hospital, Dongguan, China.
Xiaoping ChenDepartment of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Qi ChengDepartment of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Bixiang ZhangDepartment of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Peng ZhuDepartment of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0001-8088-0615

Funding

Hubei Provincial Cutting-Edge Technology Research Project 2023BAA016-3National Key R&D Program of China 2023ZD0502001National Natural Science Foundation of China 82473040Tongji Hospital High-Quality Clinical Research Fund 2024TJCR014
6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC) rupture is a life-threatening complication associated with poor prognosis. This study comprehensively analysed risk factors for HCC rupture and developed a predictive model supplemented by machine learning models for early risk identification and clinical decision-making.

methodsThis retrospective study analysed patients with and without HCC rupture from tertiary centres in China between January 2016 and June 2019. Propensity score matching (PSM) was used to reduce baseline differences between the rupture and non-rupture groups. Random forest and deep learning models were developed to enhance predictive accuracy and interpret variable importance. Model performance was evaluated using metrics such as precision, recall, and the F1 score across training, validation, and test cohorts.

resultsAmong the 5952 HCC patients, the median follow-up duration was 48.6 months. Key risk factors for HCC rupture identified in this study include cirrhosis, protrusion ratio, and tumour maximum length. The CAPTure nomogram, constructed based on these predictors, yielded area under the curve (AUC) values of 0.857, 0.824, and 0.840 in the training, validation, and test cohorts, respectively. In the test cohort, the random forest and deep learning models achieved AUCs of 0.870 and 0.872, respectively.

conclusionThis study provides a comprehensive analysis of risk factors for HCC rupture and introduces the CAPTure model as a practical and accurate tool for clinical use. By integrating traditional and machine learning approaches, the findings of this study offer robust methods for early risk assessment, resource optimization, and improved management of HCC rupture.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAgedChinaFemaleFollow-Up StudiesHumansMachine LearningMaleMiddle AgedNomogramsPrognosisPropensity ScoreRetrospective StudiesRisk AssessmentRisk Factorsmachine learningprediction modeltumour rupture

Identifiers

PMID41189483
PMCPMC12586324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.